↓ Skip to main content

Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
Published in
Journal of Experimental & Clinical Cancer Research, June 2019
DOI 10.1186/s13046-019-1211-2
Pubmed ID
Authors

Ji-Chang Wang, Guang-Yue Li, Bo Wang, Su-Xia Han, Xin Sun, Yi-Na Jiang, Yan-Wei Shen, Can Zhou, Jun Feng, Shao-Ying Lu, Jian-Lin Liu, Mao-De Wang, Pei-Jun Liu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 12%
Student > Bachelor 9 12%
Researcher 7 9%
Student > Ph. D. Student 7 9%
Student > Postgraduate 6 8%
Other 10 13%
Unknown 28 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 17%
Medicine and Dentistry 9 12%
Agricultural and Biological Sciences 9 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Engineering 3 4%
Other 8 11%
Unknown 29 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2019.
All research outputs
#22,767,715
of 25,385,509 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#1,970
of 2,382 outputs
Outputs of similar age
#316,569
of 366,665 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#71
of 87 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,382 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,665 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.